eighteen patients with obstetric and gynecologic infection ( 12 with intrauterine infections , 2 with pelvic dead space inflammation , 2 with pelvic peritonitis , 1 with a vaginal cuff abscess and 1 with a vulvar abscess ) and 1 patient with other infection ( abdominal wall abscess ) were evaluated , but 1 patient with pelvic peritonitis was later excluded from the efficacy evaluation because of a serious illness .
C0242172
pelvic
C0009450
infection